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Introduction
Research on the role of innovation on economic outcome has for long been at the heart of three different fields of the profession: macro-economics, international economics, and industrial economics. Two central assumptions can be thought of unifying these literatures, namely that innovation is endogenous at the firm-level, and it is undertaken for the sake of distinguishing products from competitors (horizontally or qualitatively) thereby securing a firm's market position against its rivals. We may associate innovation of that kind with what we will refer to as product innovation. While macro and trade economics tend to think of firm-level productivity as being determined by nature or even drawn from a lottery, there is a well-established literature in industrial organization that suggests that endogenous productivity gains are possible through process innovation.
Overall, product characteristics and high productivity are now understood as the corner stones for firms to sustain competition on the domestic but even more so on global markets. Accordingly, we hypothesize that there is a distinct role to play for product and and process innovations. Yet, their distinct impact on domestic and foreign market penetration is hitherto the target of only small bodies of theoretical and empirical work. To a large extent, product and/or process characteristics and the corresponding modes of innovation are typically viewed to be beyond a firm's choice. The latter is, however, largely at odds with both economic intuition and stylized facts.
This paper aims at contributing to previous empirical work on innovation and exports by distinguishing between the effects of product and process innovation on firm-level export propensity, and, at the same time, by taking full account of either kind of innovation's endogeneity.
The remainder of the paper is organized as follows. The next section provides an overview of earlier theoretical and empirical work on innovation to motivate determinants of innovations and derive hypotheses about their consequences for productivity and export propensity. Section 3 elaborates on the empirical framework for estimating the impact of two endogenous modes of innovation on export propensity. Section 4 summarizes the main features of our survey data. The empirical findings are presented in Section 5, they are discussed and their sensitivity is investigated in Section 6, and the last section concludes with a summary of the central findings.
Previous research and the contribution of this paper
In the subsequent discussion of previous, innovation-related economic work, it is useful to distinguish between theoretical and empirical research on the issue.
Economic theory on innovation
There is a sizeable body of theoretical work that elaborates on the determinants of innovation and their consequences for productivity and economic growth and, to a lesser extent, for exports. Macro-economists stress the importance of innovation in new products as a prerequisite for economic growth. As indicated before, innovation is endogenous itself and firms innovate more likely in large economies (where fixed costs can be covered more easily), if the (exogenous) productivity in research labs is high, product markets are competitive, and if consumers value a large variety and/or a high quality of available products (see Grossman and Helpman, 1991, chapters 3 and 4) . Implicitly, most of the related studies confine their interest to product innovation. Only recently, macro-economists explore the potential differences between product and process innovations for income, focusing on heterogeneous agents and technological unemployment (Foellmi and Zweimüller, 2005) . One key finding in the latter branch of work is that process innovation may lead to technological unemployment in the short-to-medium run which may be offset by product innovation in the long-run. While both process and product innovation spur aggregate income, product innovation is preferable by avoiding the adverse effects of technological unemployment.
International economic theory spots the role of product innovation for trade in open economy growth models (Dollar, 1986; Jensen and Thursby, 1987; Grossman and Helpman, 1989 , 1991 Segerstrom, Anant, and Dinopoulos, 1990) . As in closed-economy models of endogenous growth, market size, the productivity of research labs, consumer preferences favoring a larger variety and/or a higher quality of products, and product market competition are key determinants of innovation. An economy's openness to trade additionally fosters product market competition and, hence, creates an incentive for a firm to innovate. In turn, innovation is a prereq-uisite for firms to gain access to foreign consumer bases via exports. The latter establishes the hypothesis of innovation-driven exports. In recent dynamic models with firms that exhibit heterogeneous productivity levels and, hence, heterogeneous marginal production costs (Jovanovich, 1982; Hopenhayn, 1992; Melitz, 2003; Grossman, Helpman, and Szeidl, 2006) investment in firm-specific assets leads to a selection of firms: the least productive ones do not participate at the market at all and the most productive ones supply consumers not only at home but also abroad (through exports), while those with an intermediate productivity only face demand from domestic consumers. There, investment in firm-specific assets (to be associated with product innovation, see Spence, 1984 ) and a high corresponding outcome (i.e., a high total factor productivity) are the key determinants of a firm's export propensity.
Research in industrial economics provided pioneering results on the role of marginal cost-reducing innovations (i.e., expenditures for research and development for the sake of process innovation) in international oligopoly models more than two decades ago (Spencer and Brander, 1983) . A higher investment in such process innovations increases a firm's domestic and foreign output. However, this eventually leads to an excessive amount of innovations of that kind. The equilibrium level of (process) innovation expenditures increases with domestic and foreign market size, and it declines in the level of trade costs and the degree of product market competition (i.e., the number of competitors in the market). Subsequent research established insights in the relationship between process innovation and competitive pressure at the local (Martin, 1993) and the global level (Baily and Gersbach, 1995) . More recently, an explicit treatment of product versus process innovations and the role of competitive pressure has been delivered by Boone (2000) . The impact of product market competition on a firm's product and process innovations crucially depends on the firm's efficiency relative to its competitors. When assuming that the aggregate efficiency can be measured by the (inverse of) average production costs, then, Boone's (2000) analysis suggests that a higher level of competitive pressure cannot increase product and process innovation at the same time. Rather, an increase in the competitive pressure may increase the efficiency of each surviving firm but lead to the exit of less productive ones, which is associated with a decline in product innovation. Overall, a positive impact of competitive pressure on process innovation is a possible, yet not a necessary outcome. 
Empirical work on the determinants and effects of innovation
Numerous previous empirical studies point to a positive impact of innovation on exports at the firm-or plant-level. Some of the related studies rely on R&D expenditures as an indirect measure of innovations (Hirsch and Bijaoui, 1985; Kumar and Siddharthan, 1994; Braunerhjelm, 1996; Basile, 2001 ) and a smaller number of studies employs survey data with explicit information on the actual innovations (Wakelin, 1998; Bernard and Jensen, 1999; Roper and Love, 2002; Cassiman and Martínez-Ros, 2004; Lachenmaier and Wößmann, 2006) . Overall, these studies point to a strong positive impact of innovations on exports.
1 While most of the mentioned studies were carried out in crosssectional data-sets, there is evidence of a positive impact of innovation on exports (or export growth) also in panel data-sets (Hirsch and Bijaoui, 1985; Cassiman and Martínez-Ros, 2004) .
Surprisingly, in as much as the aforementioned theoretical models establish an endogenous determination of innovations, and economic theory on innovation and exports addresses their simultaneous determination (Hughes, 1998) , empirical micro-econometric work on innovation-driven exports tends to model the selection of firms into innovations as a random (or exogenous) process. Two exceptions in the latter regard are Cassiman and Martínez-Ros (2004) and Lachenmaier and Wößmann (2006) . Both studies exploit information from panel data. Cassiman and Martínez-Ros (2004) focus on innovations as such and treat them as predetermined variables (hence, they use once-lagged instead of contemporaneous innovations in the export regressions). Lachenmaier and Wößmann (2006) apply instrumental-variable procedures to account for the potential endogeneity of innovations. One of their major findings is that innovations are indeed endogenous and their exogenous treatment leads to largely downward-biased estimates of the impact of innovations on firm-level exports.
Contribution of this paper
This paper departs from the strategy adopted in previous micro-econometric work on the innovation-driven exports hypothesis in two important ways.
First, it explicitly distinguishes between product and process innovations in the analysis and, second, it accounts for their endogeneity by allowing for an endogenous selection of firms into product and process innovations.
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In contrast to earlier work, we use matching techniques for multiple binary treatments -in our case, new product and/or process innovations versus no innovations at all -to account for self-selection of firms into either type of innovation.
Empirical framework
In the subsequent analysis we assume that, after controlling for a set of observable variables, treatment participation does not depend on treatment outcome. The latter is also referred to as the assumption of conditional mean-independence (see Wooldridge, 2002) . One strategy of exploiting this assumption for the purpose of treatment effect identification is propensity score matching (see Angrist, 1998; Wahba, 1999, 2002; Todd, 1997, 1998; Lechner, 2001; Heckman, LaLonde, and Smith, 1999 , provide a survey).
Since our data set allows us to disentangle product innovation from process innovation -hence, there are two treatment indicators at the firm level -, we have to depart from the strategy typically applied in models with a simple binary treatment variable. Obviously, the choice set from a firm's perspective can not be captured by a single binary indicator, but rather it spans a 2×2 matrix of mutually exclusive innovation-related treatments. Let us use superscripts 0, d, and c to indicate the cases of no treatment, product 2 Cohen and Klepper (1996) formulate and test a model of the determinants of product as well as process innovation in a cross-sectional data-set of 587 U.S. firms. They find that large firms, in accordance with their model, have a greater incentive to pursue both process and product innovations. However, these firms face a relatively larger incentive to undertake process and more incremental innovations as compared to small ones. Martínez-Ros (2000) provides an empirical analysis of the determinants of product and process innovations in a Spanish firm-level data-set. Neither of these studies considers the impact of these two modes of endogenous innovations on exports. Basile (2001) looks at the effect of product and process innovations (measured by two different R&D expenditure modes) on exports, but he treats innovations as exogenous. The paper by Lachenmaier and Wößmann (2006) also distinguishes between product and process innovations, but only in one of the specifications in the sensitivity analysis. There, neither the impact of product innovations nor that one of process innovations on exports is significantly different from zero.
innovation, and process innovation, respectively. Then, the four mutually exclusive treatments are (0, 0) (the no treatment case), (d, 0) (new product innovations only), (0, c) (new process innovations only), and (d, c) (both new product and new process innovations).
3 A matching approach with multiple treatments has been derived by Lechner (2001) .
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For convenience, let us refer to the no treatment outcome as Y (0,0) (i.e., the corresponding export propensity as captured by a binary firm-level export indicator). The remaining possible outcomes are
, respectively. Let us use superscripts m and l as running indices for the four treatments to determine three different types of treatment effects (see Lechner, 2001 ). The expected average effect of treatment m relative to treatment l for a firm drawn randomly from the population is defined as
The expected average effect of treatment m relative to treatment l for a firm randomly selected from the group of firms participating in either m or l is defined as
where S is the assignment indicator, defining whether a firm receives treatment m or l. Finally, the expected average effect of treatment m relative to treatment l for a unit that is randomly selected from the group of firms participating in m only is defined as
Note that both γ m,l and α m,l are symmetric in the sense that
and α m,l = −α l,m , whereas θ m,l is not, so that θ m,l = −θ l,m . Estimates of the average treatment effects can be obtained as follows. First, the response probabilities for each treatment can be estimated either by a bivariate probability model (it is customary to use a logit or a probit model). Denote the estimated response probabilities that are a function of the vector
We apply radius matching (each treated firm is compared to all firms within a certain radius around its propensity score), nearest-neighbor matching (each treated firm is compared to a single control unit), and kernel matching (each treated unit is compared to all untreated firms in a certain area around the propensity score depending on the bandwidth of the kernel, but inversely weighted with their difference in propensity score to the treated unit). The average treatment effect (i.e., the outer expectation above) is estimated as the average of the difference in outcomes between the treated and the control units.
We pursue two alternative estimates of the standard error of each of the treatment effects. First, we compute analytic standard errors as in Lechner (2001) . The analytic standard errors for the three treatment effect concepts are
In empirical applications, these analytical standard errors may deviate considerably from their small-sample-counterparts. Therefore, we alternatively compute sub-sampling-based standard errors following Politis, Romano, and Wolf (1999) . As shown by Abadie and Imbens (2006) these give reliable variance estimates of treatment effects even in small samples.
Data
Our data are based on the Ifo Innovation Survey that is conducted annually by the Ifo Institute, covering more than 1,000 firms in Germany per year.
The survey asks about the structure of innovations at the firm level. In particular, it collects information about process versus product innovation activities and about export status. Furthermore, the survey explicitly covers questions relating to exogenous innovation impulses and obstacles as well as other firm-level characteristics. Beyond that, there is an industry indicator that allows us to link industry characteristics to the micro-level data.
Dependent variables
Regarding the dependent variables, the database provides information on whether a firm has exported and applied new product innovations or process innovations over the last six months or not. The corresponding questions that we rely on in our analysis can be translated as follows:
• We did not export (in year t). As our outcome variable, we construct a dummy variable that takes a value of one if firms export and zero if they do not.
• In the year t we have introduced (or started but not yet finished) new product innovations. In the year t we have introduced (or started but not yet finished) new process innovations. We use the answers to these questions to construct two dummy variables, one that takes on a value if new product innovations were undertaken in year t and zero else, and the other is constructed in the same way but for process innovations.
Overall, there are 1, 537 firms and 4, 499 observations in our database. Note that every observation covers three years of data because our outcome is measured in t + 1, the treatment in t and pre-treatment variables in t − 1. A cross-tabulation for export propensity and the two innovation indicators is provided in Table 1 . The entries can be summarized as follows. First, 80.00 percent of the firms in our sample conduct exports. The high fraction of exporters is not surprising, since, by design, the survey covers mainly large manufacturing firms. Second, 61.96 percent of the firms innovate (i.e., they receive treatments (d, 0), (0, c), or (d, c)). Of those, 23.57 percent conduct 
Independent variables
Beyond the information for the dependent variables in our analysis, the survey asks about a set of incentives/impulses and obstables/impediments to innovation. Of those, in our empirical model, only the following four impediments exert a significant impact on a firm's probability to innovate: lacking own capital; lacking external capital; long amortization period; imperfect opportunities to cooperate with public or academic institutions. For these obstacles to innovation, multiple answers are possible and they are numerical: 1 (not important at all); 2 (not very important); 3 (important); 4 (extremely important). We generate a binary variable for each impediment and classify 3 and 4 as one and 1 and 2 as zero. Furthermore, we include lagged logarithms of sales and employment at the firm level as two separate regressors. In addition to these firm-level determinants we use characteristics that vary across NACE 2-digit industries published by EUROSTAT (NewCronos Database). In particular, we employ the once lagged German real value added in nominal Euros (to capture the size of an industry), real value added per worker (to capture industry productivity), and unit labor costs (to capture wage costs per unit of output). Furthermore, we use inverse-distance weighted values of these variables for the EU14 economies (excluding Germany). There, each industrylevel explanatory variable x ijt for industry i and time t is weighted across the 14 EU member countries as of 1995 excluding Germany according tõ
5 The industry-level variables control for both a firm's competitive pressure at the domestic and the Western European foreign markets. For instance, the inverse-distance weighted value added can be interpreted as a measure of the foreign potential supply. The higher the latter, the stronger we conjecture competition to be for German producers. By way of contrast, the higher the weighted foreign wage costs are relative to foreign output, the lower we expect the competitive pressure for German producers to be ceteris paribus. Table 2 summarizes mean and standard deviation of all covariates. Table 3 presents the results of a multinomial logit model (assuming a logistic cumulative density function, respectively) determining a representative firm's choice of product and/or process innovation. In Table 9 in the Appendix, we report the corresponding findings based on a bivariate probit model (assuming a bivariate normal cumulative density function of the latent outcome variable).
Estimation results
The estimates and test statistics reported in Tables 3 and 9 suggest the following conclusions. First, the value of the log-likelihood under the bivariate probit model is −4312.14 while that one under the multinomial logit is −4241.27. Davidson and MacKinnon (2004) suggest selecting among such non-nested, non-linear probability models according to a likelihood ratio statistic based on twice the absolute difference in the corresponding loglikelihoods (LL): LR = 2|LL probit − LL logit |. This test statistic is distributed as χ 2 (13). Following this device, we find that the statistic amounts to 141.71, which is significant at the one percent level. Hence, the data are more appropriately described by the multinomial logit model, which we also use in the sequel for matching.
Furthermore, the test statistics indicate that domestic industry variables and weighted EU14 industry variables are group-wise and jointly significant at the one percent level in the model. Similarly, the included innovation impediments are jointly significant.
To check whether propensity score matching achieves better balancing of the variables in our model, we calculate the reduction of the median absolute standardized bias in the observables included in the selection models between the treated firms and all control units versus the treated and the matched control units. While there is no firm rule of thumb, the statistics literature suggests that the remaining bias should definitely be smaller than 20 percent (Rosenbaum and Rubin, 1985) . In our case, the median bias between the treated and the matched control units amounts to about 8 percent, which seems reasonable. In the case of statistically significant effects, the bias reduction is even larger. For instance, for the effect (d, c) versus (0, 0), the median absolute standardized bias drops from 32.70 to 3.05. Overall, matching reduces the bias by about two thirds. Similarly, comparing the pseudo-R 2 of the propensity score estimation before and after matching, we find a significant drop in explanatory power. For instance, for the effect (d, c) versus (0, 0), the pseudo-R 2 before matching is 0.354, i.e., the covariates are relevant predictors in the overall sample. However, in the matched sample of nearest neighbors, the pseudo-R 2 of the same selection regression drops to 0.037, i.e., in the matched sample, there is no remaining systematic difference in observables between treated and control firms. Put differently, our matching procedure does a good job in balancing firm and sector characteristics and allows us to match comparable firms as required.
Based on these findings, we can turn to estimating the various treatment effects of product and process innovations on firm-level export propensity. Here, we use a radius matching as our reference model outcome. This type of matching requires that the matched control units exhibit a propensity score that differs by not more than the radius from the propensity score of the treated unit they are matched onto. Hence, in contrast to other matching estimates such as k-nearest neighbor matching or kernel matching, radius matching enforces a certain matching quality depending on the size of the radius (see Smith and Todd, 2005 , for a discussion). We choose a radius of 0.05 in our benchmark model. However, we consider alternative matching estimators and a smaller radius in the sensitivity analysis. The most important findings based on the chosen procedure are summarized in Table 4 . 6 Our results indicate that the analytical standard errors are slightly more conservative (i.e., smaller) than the bootstrapped ones. In the subsequent discussion we will base our inference on bootstrapped rather than analytical standard errors.
Overall, the results indicate that there is a strong, positive role to play for product innovation for a firm's propensity to export. For instance, firms that conduct new product and process innovations (the treated -T in the first table column -receive (d, c)) exhibit a significantly higher export propensity than ones that neither do product nor process innovations (the matched controls -C in the second table column -receive (0, 0)). The estimates suggest that firms receiving the treatment (d, c) exhibit an export propensity that is about 8 percentage points higher than for those receiving the treatment (0, 0). Firms receiving the treatment (0, 0) (i.e., no innovation at all) exhibit an export propensity that is about 13 percent lower than for ones with treatment (d, c). These two ATTs are significantly different from zero at conventional levels. The average treatment effect of (actually or hypothetically) receiving the treatment process and product innovation (d, c), given that a firm receives either (d, c) or (0, 0), isα ≈ 0.10. Hence, product and process innovation together enhance a firm's export propensity by about 10 percentage points. Similar conclusions apply for the ATE: product and process innovation together increase a firm's propensity to export by about γ ≈ 0.11 -i.e., 11 percentage points -, irrespective of and unconditional on which treatment it actually received.
The effect of product innovation is even stronger if a firm already engages in process innovation. This can be seen from a comparison of the point estimates in the third and fourth rows in the table where the treated T receive (d, c) and (0, c), respectively, and the matched control units C receive (0, c) and (d, c), respectively. These point estimates are larger in absolute values than those in the first and second lines, irrespective of whetherθ, α, orγ are considered. Even switching from process to product innovation entails significant positive effects on export propensity (consider the two rows at the bottom of Table 4 ). While product innovations alone raise a firm's propensity to export significantly (see lines 7-8 in the table), their impact is larger if process innovations were already realized. By way of contrast, there is no significant increase in export propensity to be expected if an already product innovating firm undertakes process innovation, in addition. Similarly, process innovations alone exert an insignificant impact on export propensity (see lines 9-10 in the table).
Is there any gain from matching in this data set? To shed light on this issue, we may compare the average treatment effect under the assumption of exogeneity of all regressors, (γ exog. ), with its endogenous counterpart as reported in Table 4 (γ). The exogenous treatment effect may be thought of as the simple comparison of the average export propensity among the treated and the untreated firms for each treatment. The corresponding exogenous treatment effect estimates (i.e., the simple mean comparisons) together with their endogenous treatment effect counterparts as of Table 4 are summarized in Table 5 . Since the average treatment effects are symmetric throughout, we only report every second estimate as compared to Table 4 .
It seems worth noting that in one of the experiments even the sign of the exogenous treatment effect point estimate differs from the endogenous one (namely with treatment (0, c) and controls (d, 0), i.e., T − C of (0, c) − (d, 0)). Moreover, for five of the six parameters the (absolute) difference in the point estimates is higher than 50 percent of the endogenous treatment effect parameter. In many of these cases this difference is significant. Hence, accounting for self-selection into treatment is important in this data set, leading to significantly different average treatment effect estimates. d, c) -(0, c) .091 .020 .140 .065 (06) (d, c) -(d, 0) .014 .017 .031 .037 (08) Table 4 .
Sensitivity analysis and discussion
We undertake several robustness checks to assess the sensitivity of our findings. In these experiments, we only report re-sampling-based standard errors of the endogenous treatment effect estimates for the sake of brevity. First, we consider an alternative radius of only 0.005 instead of 0.05. Hence, we enforce a considerably higher precision of the matching estimates there than we did in our benchmark model in Table 4 . Second, we use a nearest neighbor matching estimator, where we compare each treated firm's outcome to a single nearest neighbor, irrespective of the difference of the best match's difference in propensity score to the treated unit (i.e., the difference might be smaller or larger than than 5 or 0.05 percentage points as required with the previous radius matching estimates). Third, we use an Epanechnikov kernel-based matching with a bandwidth of 0.06 instead of the original radius matching. This kernel estimator is potentially more efficient than the radius matching estimator but it gives some weight to less comparable units than radius matching with a narrow radius does. The bandwidth determines this trade-off between efficiency and unbiasedness. Let us refer to a control unit's absolute difference to a treated firm's propensity score as ∆. Then, only those firms with ∆ ≤ 0.06 are given a weight of 1 − (∆/0.06) 2 and zero else. Hence, a larger bandwidth covers more observations and gives more weight to less comparable ones. Fourth, we infer to which extent kernel matching depends on the choice of the kernel bandwidth. For this we choose a much narrower bandwidth of 0.02 which mimics (but is not identical to) the choice of a smaller radius under radius matching. Fifth, we use an alternative kernel, namely a Gaussian one with a bandwidth of 0.06. There, the kernel weight is φ(∆/0.06), where φ(·) is the normal density and ∆ is the absolute difference in propensity scores between a treated and a control unit. Finally, we use the lagged export indicator as a determinant for innovation activities at time t. For instance, the latter ensures that we estimate the impact of innovation on export propensity from a comparison of treated firms with untreated ones where the export status in the past was the same between the treated and the untreated.
The results are presented in three tables. Table 6 summarizes the ATT estimates (θ m,l ) for all sensitivity checks, Table 7 the estimates ofα m,l , and Table 8 those of ATE (γ m,l ). For convenience, the first column in each of these tables captures the benchmark results and is repeated from Table 4 . Let us start with the ATT estimates. Across the board, neither changing the radius nor the matching estimator (nearest neighbor or alternative kernel matching estimators with different bandwidths instead of radius matching) affects our conclusions from above, neither in qualitative nor in quantitative terms.
Even considering lagged export status as a determinant of innovation mode does not change the findings in qualitative terms. However, the parameter point estimates of the treatment effects are smaller in absolute value (see column (7) in Table 6 ). There are two interpretations for the latter. First, inference about the corresponding estimates is based on a smaller sample as before since one year is lost when using lagged exports and only those observations can be used where the lead and lag of exports is available for a firm. Second, in this experiment we rule out any impact of innovations on future export propensity triggered by heterogeneous export status in the past. Accordingly, the matched controls are different from the ones in the original experiments. Similar conclusions apply for the estimates in Tables 7 and 8 . Overall, neither the functional form of the multiple choice model, nor the alternative values for the radius, the type of the matching estimator (radius versus nearest-neighbor versus kernel), nor the kernel bandwidths or the functional forms of the kernels have a qualitative impact on the significant findings in the original table. Again, the impact of innovations is quantitatively smaller if we use lagged export status as a determinant of contemporaneous innovation mode in the selection models. However, most of the originally significant estimates remain significant even in this case and none of the 24 estimated point estimate signs in column (7) of Tables 7 and 8 is different from those in the other columns of the same tables.
In general, this paper's analysis provides robust evidence that product innovation is more important than process innovation for a firm's export propensity. However, while process innovation seems of little relevance for export propensity, it improves a firm's probability to export if it is accompanied by product innovation.
Conclusions
Our goal in this paper was to provide novel empirical insights in the role of product versus process innovation on export propensity at the firm level. Either of these modes of innovation has been hypothesized to affect firm-level productivity in previous theoretical work. A smaller body of theoretical research even pointed to the differential impact of these two types of innovation on a firm's export propensity. We aim at assessing the latter relationship empirically. Economic theory suggests that firms do not undertake innovations at random, neither product nor process innovations. Hence, empirical work should pay attention to the likely self-selection of firms into innovations. Viewing innovations as a 'treatment', this lends support to an endogenous treatment approach to innovations and export propensity. With two modes of innovations -product and process innovations -, one is then faced with an econometric framework with multiple endogenous treatments.
Adopting a so-called matching approach based on the propensity score and using survey data of German firms available from the Ifo Institute, we find that there is significant bias of the impact of product and process innovations on export propensity when ignoring self-selection into either mode of innovation. This bias was quite substantial in our application, having been particularly large for firms with only product or process innovations as compared to ones that did not innovate. The largest estimated self-selection bias in the data amounted to more than 200 percent, depending on the mode of innovations (product and/or process innovation).
Overall, the results point to the importance of product innovation relative to process innovation. In comparison, there is no evidence that process innovation fosters a firm's propensity to export beyond product innovation. This can be viewed as evidence on the importance of the extensive margin in product space for a firm's entry into export markets, lending support to new trade and endogenous growth theories with their emphasis on product innovations. 
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